| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/23/2007 | CN1965857A Eye drop of povidone iodine and preparation process thereof |
| 05/23/2007 | CN1965856A Heparin sodium injection liquid used for venous retention needle |
| 05/23/2007 | CN1965855A Microecological formulation for treating and caring mouth cavity disease |
| 05/23/2007 | CN1965854A Moisturizing eye drop and preparation process therof |
| 05/23/2007 | CN1965853A Application of gentiopicroside in preparation of antiviral medicament |
| 05/23/2007 | CN1965852A Aloeresin D and effective component, preparation process, pharmaceutical composition and use thereof |
| 05/23/2007 | CN1965851A Composition prepared by ambroxol and four kinds of antibacterials respectively |
| 05/23/2007 | CN1965850A Roxithromycin injection and preparation process thereof |
| 05/23/2007 | CN1965849A Composition extracted from Chinese medicinals for treating coronary heart disease and method for preparing ingredients thereof |
| 05/23/2007 | CN1965848A Lyophilized powder injection of breviscapinum and preparation process thereof |
| 05/23/2007 | CN1965847A Amikacin solution containing clustered water used for animal |
| 05/23/2007 | CN1965846A Neomycin sulphate solution containing clustered water used for animal |
| 05/23/2007 | CN1965845A Drop pills of ginsenoside monomer and preparation process thereof |
| 05/23/2007 | CN1965844A Nasal administered pharmaceutical composition containing glycyrrhetic acid and medical use thereof |
| 05/23/2007 | CN1965843A Use of statin and aspirin in preparation of medicine for treating blood high viscosity syndrome |
| 05/23/2007 | CN1965842A Intra-uterus administered medicinal stick of danazol and preparation process thereof |
| 05/23/2007 | CN1965841A Compound emulsion of hydrocortisone butyrate |
| 05/23/2007 | CN1965840A Method for preventing weight increase caused by antipsychotic |
| 05/23/2007 | CN1965839A Sustained release microsphere of finasteride and its analogue, preparation process and use thereof |
| 05/23/2007 | CN1965838A Pharmaceutical composition containing cefpiramide and beta-lactamase inhibitor |
| 05/23/2007 | CN1965837A Ofloxacin solution containing clustered water used for animal |
| 05/23/2007 | CN1965836A Oral solid formulation and its preparation method |
| 05/23/2007 | CN1965835A Sarafloxacin hydrochloride solution containing clustered water used for animal |
| 05/23/2007 | CN1965834A Enrofolxacn solution containing clustered water used for animal |
| 05/23/2007 | CN1965833A 3CL protease inhibitor of non-peptide SARS coronavirus and use thereof |
| 05/23/2007 | CN1965832A Compound injection of idazoxani hydrochloride and preparation process thereof |
| 05/23/2007 | CN1965831A Application of yohimbine and berberine mixture in medicament preparation |
| 05/23/2007 | CN1965830A Compound prescription of Chinese medicinal effective ingredients having anti-neovascularization synergetic effect |
| 05/23/2007 | CN1965829A Injection of palonosetron and preparation process thereof |
| 05/23/2007 | CN1965828A Danofloxacin mesylate solution containing clustered water used for animal |
| 05/23/2007 | CN1965827A Difloxacin hydrochloride solution containing clustered water used for animal |
| 05/23/2007 | CN1965826A Compound medicament for treating gastric diseases |
| 05/23/2007 | CN1965825A Ocular surface applied medicament for treating eyes immunological disease and inhibiting proliferation and neovascularization |
| 05/23/2007 | CN1965824A Pharmaceutical salt of ornidazole and L- ornidazole, preparation process and use thereof |
| 05/23/2007 | CN1965823A Preparing methods of (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione and its compound |
| 05/23/2007 | CN1965822A Sustained release formulation of bilobalide-B and preparation process thereof |
| 05/23/2007 | CN1965821A Oral formulation of danshensu and safflower yellow and preparation process thereof |
| 05/23/2007 | CN1965820A Lipid microsphere, lyophilized lipid microsphere containing docetaxel and preparation process thereof |
| 05/23/2007 | CN1965819A Nanoemulsion of aceclofenac for treating rheumatoid arthritis and preparation process thereof |
| 05/23/2007 | CN1965818A Prescription for preparing high-quality tranexamic acid injection and preparation process thereof |
| 05/23/2007 | CN1965817A Sustained release tablet of glibenclamide and preparation process thereof |
| 05/23/2007 | CN1965816A Medicament for preventing and treating bacterial disease of domestic silkworm and preparation process thereof |
| 05/23/2007 | CN1965815A Intravenous injection/inhalation dual-purpose general anesthetic and preparation process thereof |
| 05/23/2007 | CN1965814A Cataplasma of bulleyaconitine A |
| 05/23/2007 | CN1965813A Compound soft capsule of propolis |
| 05/23/2007 | CN1965812A Two kinds of tablet of cinnamyl aldehyde and preparation process thereof |
| 05/23/2007 | CN1965811A Sustained release tablet of calcium dobesilate and preparation process thereof |
| 05/23/2007 | CN1965808A Self-emulsifying composition of beta-11 betamethasone, preparation process and application thereof |
| 05/23/2007 | CN1965807A Fat emulsion injection prepared by using saturated fatty acid lecithin |
| 05/23/2007 | CN1965806A Fat emulsion injection liquid containing soybean oil, medium chain triglyceride, olive oil and fish oil and method for preparing the same |
| 05/23/2007 | CN1965805A Submicron emulsion injection liquid of CoQ10 and preparation process thereof |
| 05/23/2007 | CN1965804A Hydrogel suppository of berberine hydrochloride and preparation process thereof |
| 05/23/2007 | CN1965803A Non-aerosol type composition for foaming agent and foaming agent using the composition |
| 05/23/2007 | CN1965735A Medicinal pillow filled with tartary buckwheat shell and preparation process thereof |
| 05/23/2007 | CN1965697A Health beverage capable of nourishing blood |
| 05/23/2007 | CN1965657A Method for preparing flour nutrition intensifying Vitamin A microcapsule |
| 05/23/2007 | CN1965651A Disinfectant containing clustered water for animal |
| 05/23/2007 | CN1965650A Multiple metal ion chelated green antibacterial agent of chitosan |
| 05/23/2007 | CN1317301C Modulation of IL-2-and IL-15-mediated T cell responses |
| 05/23/2007 | CN1317291C Oligonucleotide N3'-P5' thiophosphoramidates, their synthesis and use |
| 05/23/2007 | CN1317288C Method for producing tablet, baked product or chewing gum |
| 05/23/2007 | CN1317280C Novel diazabicyclic aryl derivatives |
| 05/23/2007 | CN1317278C Heterocyclic compounds and their use as medicines |
| 05/23/2007 | CN1317277C Benzofuran derivatives and their use as antibacterial agents |
| 05/23/2007 | CN1317274C 1-phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives |
| 05/23/2007 | CN1317273C Compound having thiofuran and acetylene ethylene bond, its preparation method and use |
| 05/23/2007 | CN1317265C Cyanoacrylate derivatives and their preparation method and biological activity |
| 05/23/2007 | CN1317042C Biologic external application medicine for curing wound |
| 05/23/2007 | CN1317031C Efficient mixture preparation for intensifying solid tumor cell chemical therapeutic sensitivity |
| 05/23/2007 | CN1317030C Treatment of dementia and neurodegenerative diseases with intermediate doses of lhrh antagonists |
| 05/23/2007 | CN1317025C Chinese medicine for treating high fever and its preparation method |
| 05/23/2007 | CN1317017C Externally applied medicine for treating skin ulcer |
| 05/23/2007 | CN1317005C Dragon's blood extract with alpha-glycosidase inhibiting activity and its prepn making process and use |
| 05/23/2007 | CN1316988C Heart disease treating Chinese medicine composition |
| 05/23/2007 | CN1316985C Novel use of extractive from sapan wood |
| 05/23/2007 | CN1316983C Echinacea angustifolia extracts |
| 05/23/2007 | CN1316978C Compound glucosamine sulfate dispersible tablet formulation and its preparation method |
| 05/23/2007 | CN1316977C Stabilized brivudine topical formulations |
| 05/23/2007 | CN1316976C Use of kaempferol-3-O-glubulariacitrin in preparing medicine for senile dementia |
| 05/23/2007 | CN1316975C Puerarin prepn for eye and its prepn process |
| 05/23/2007 | CN1316974C Combination of medication for treating skin ulcer |
| 05/23/2007 | CN1316973C Beta-carotene clathrate and its preparation method |
| 05/23/2007 | CN1316972C Anti-cancer analgetic preparation |
| 05/23/2007 | CN1316971C Pharmaceutical composition with sustained release function and its preparing process |
| 05/23/2007 | CN1316970C Solid dispersed matter of hydroxyl-camptothecin and its formulation |
| 05/23/2007 | CN1316969C Ophthalmic preparation of fluconazole and method for preparing the same |
| 05/23/2007 | CN1316968C Application of indole-2,3-diketone in preparing medication for antivirus or immunopotenfiator |
| 05/23/2007 | CN1316967C Diclofenac diethylamine gel agent |
| 05/23/2007 | CN1316966C Otacosane alcohol extract micro-encapsulation powder and preparation method thereof |
| 05/23/2007 | CN1316923C Method preparing micrometer western and Chinese wolfberry essence, bee glue, chromium yin nourishing, and sugar reducing oral liquor |
| 05/23/2007 | CN1316921C Health-care food containing ganoderma polysaccharide and tea polyphenol |
| 05/23/2007 | CA2568504A1 Local vascular delivery of p13 kinase inhibitors alone or in combination with sirolimus to prevent restinosis following vascular injury |
| 05/22/2007 | US7220897 Δ4-desaturase genes and uses thereof |
| 05/22/2007 | US7220880 For therapy of diabetes mellitus, cardiovascular disease, obesity, Syndrome X and gastrointestinal disease, such as, inflammatory bowel disease |
| 05/22/2007 | US7220876 Arylcycloalkyl derivatives having branched side chains, processes for their preparation and their use as pharmaceuticals |
| 05/22/2007 | US7220875 Amino acid derived prodrugs of propofol, compositions and uses thereof |
| 05/22/2007 | US7220871 taxane is prepared by esterifying an appropriate baccatin carrying a C-13 hydroxyl functional group with an acid derivative and is obtained by controlled saponification |
| 05/22/2007 | US7220867 Dissolving with crystal growth inihibitos; drying |
| 05/22/2007 | US7220866 Useful in the treatment of diseases or conditions susceptible to adrenergic regulation controlled by alpha-2 adrenergic receptors |
| 05/22/2007 | US7220865 For therapy of neurodegenerative and/or neurological disorders, e.g., Alzheimer's disease, in a mammal |